tert-Butyl bromoacetate → DI-T-Butyl iminodiacetate

HRID 1397109ノート

反応式

HRID 1397109 の反応式
[NH2:1][C@H:2]([C:7]([OH:9])=[O:8])C(C)(C)C.Br[CH2:11][C:12]([O:14][C:15]([CH3:18])([CH3:17])[CH3:16])=[O:13]>C(#N)C>[C:12]([O:14][C:15]([CH3:18])([CH3:17])[CH3:16])(=[O:13])[CH2:11][NH:1][CH2:2][C:7]([O:9][C:15]([CH3:18])([CH3:17])[CH3:16])=[O:8]

参加物

4

反応物 2

HCID 79177tert-Butyl bromoacetateHCID 164608L-tert-Leucine

生成物 1

HCID 4393691DI-T-Butyl iminodiacetate収率 67.2%

試薬・触媒・溶媒 1

HCID 6342Acetonitrile溶媒

実験手順

To a solution of t-butylglycine (1.40 g, 10.67 mmol) in acetonitrile (20 mL) cooled to 0° C. was added ethyldisopropylamine (1.86 mL, 10.67 mmol) and t-butyl bromoacetate (1.57 mL, 10.67 mmol). The resulting solution was stirred for 24 h at room temperature. The mixture was concentrated to dryness in vacuo, water was added and the solution was extracted with dichloromethane (3×70 mL). The combined organic phases were washed with brine (70 mL), dried over Na2SO4 and concentrated to dryness in vacuo. The crude material was purified by silica gel chromatography (20-80% EtOAc in hexanes) to give the compound 14 (0.88 g, 33.6%). 1H NMR (400 MHz, CDCl3) δ 1.43 (s, 18H), 3.30 (s, 4H).

後処理

  1. concentrationThe mixture was concentrated to dryness in vacuo, water
  2. additionwas added
  3. extractionthe solution was extracted with dichloromethane (3×70 mL)
  4. washThe combined organic phases were washed with brine (70 mL)
  5. dry with materialdried over Na2SO4
  6. concentrationconcentrated to dryness in vacuo
  7. customThe crude material was purified by silica gel chromatography (20-80% EtOAc in hexanes)

出典と根拠

ORDレコード
ord-198517d0fac94c42853f8dbcc2e369df
出典データセット
uspto-grants-2014_12
特許番号
US08901072B2

反応ノート

読み込み中…